|Save ComparisonClear all|
A South San Francisco, CA-based biopharmaceutical company.
Aprea Therapeutics is a pharmaceutical development company, engaging in the discovery and development of anticancer compounds that target tumor suppressor proteins.
Pulmocide is a biopharmaceutical company with a mission to treat common acute and chronic respiratory tract infections.
Nosopharm is a biotechnology company dedicated to anti-infective drug discovery, targeting the bacterial multidrug resistance to antibiotics.
Visterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases.
South San Francisco, US HQ
Solna, SE HQ
London, GB HQ
Nîmes, FR HQ
Cambridge, US HQ
Latest funding round
Latest funding round$ 33m (over 1 year ago)
Latest funding round$ 50.5m (about 2 years ago)
Latest funding round$ 30m (about 1 year ago)
Latest funding round$ 2.6m (about 1 year ago)
Latest funding round$ 23.6m (8 months ago)
Total funding raised
Total funding raised$ 33m
Total funding raised$ 50.5m
Total funding raised$ 57.5m
Total funding raised$ 3.8m
Total funding raised$ 122.1m